Economic burden of patients living with heart disease in the last years of life in Australia: a retrospective analysis using linked data

被引:2
|
作者
Kularatna, Sanjeewa [1 ]
Senanayake, Sameera [1 ]
Parsonage, William [1 ,2 ]
Jun, Deokhoon [3 ]
McPhail, Steven [1 ,4 ]
机构
[1] Queensland Univ Technol QUT, Fac Hlth, Australian Ctr Hlth Serv Innovat & Ctr Healthcare, Sch Publ Hlth & Social Work, 60 Musk Ave, Kelvin Grove, Qld 4059, Australia
[2] Metro North Hlth, Royal Brisbane & Womens Hosp, Herston, Qld 4059, Australia
[3] Metro South Hlth, Clin Informat Directorate, Brisbane, Qld, Australia
[4] Metro South Hlth, Clin Informat, Brisbane, Qld, Australia
关键词
Heart disease; Hospital costs; End of life care; OF-LIFE; MULTIMORBIDITY; CANCER; CARE; END;
D O I
10.1093/ehjqcco/qcab006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims People living with heart disease are at elevated risk of hospitalization during the last years of their life. The aim of this study was to describe hospitalization-related usage patterns, and associated cost burden, for patients living with heart disease in the last 6 years of their life. Methods and results The study was an observational cohort study, using routinely collected and linked data from hospital admission (HA), emergency department (ED) presentation and death registry data in Queensland, Australia. The study sample included 1000 randomly selected patients who died in 2017 due to any cause who had been living with heart disease for at Least the prior 6 years. The two main outcomes of interest in this study were cost of HAs and cost of ED presentation in the Last 6 years before death. Total cost was calculated as a sum of direct and overhead costs from each of the hospital presentations. The mean HA per patient in the sixth year, second year, and last year prior to death was 5.3, 6.6, and 7.5, respectively, with a similar pattern observed for ED presentations. The associated costs per patient from HA followed a similar trajectory increasing gradually from $17 711 in the sixth year to $26 658 in the second last year prior to death. A similar pattern was observed for ED presentation costs. Conclusion The large increase cost in the last year of life was primarily attributable to higher treatment cost per HA at end of life.
引用
收藏
页码:333 / 341
页数:9
相关论文
共 50 条
  • [41] Increased Economic Burden of Uveitis Among Patients with Psoriasis and Psoriatic Arthritis - a Retrospective Study Using Claims Data, 2009-2022
    Husni, M. Elaine
    Thorne, Jennifer
    Peterson, Steve
    Shiff, Natalie
    Neff-Baro, Shanti
    Lin, Iris
    Teneralli, Rachel
    Adejoro, Oluwakayode
    Merola, Joseph
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4365 - 4367
  • [42] The Clinical and Economic Burden of Antibiotic Use in Pediatric Patients With Varicella Infection: A Retrospective Cohort Analysis of Real-World Data in England
    Kujawski, Stephanie A.
    Banks, Victoria
    Casey, Caroline S.
    Drysdale, Simon B.
    Patel, Amisha
    Massey, Olivia
    Holbrook, Tim
    Pawaskar, Manjiri
    JOURNAL OF INFECTIOUS DISEASES, 2023, 230 (01): : e65 - e74
  • [43] The economic burden of metastatic and prostate specific antigen progression in patients with prostate cancer: Findings from a retrospective analysis of health plan data
    Penson, DF
    Moul, JW
    Evans, CP
    Doyle, JJ
    Gandhi, S
    Lamerato, L
    JOURNAL OF UROLOGY, 2004, 171 (06): : 2250 - 2254
  • [44] Primary care usage at the end of life: a retrospective cohort study of cancer patients using linked primary and hospital care data
    Grant, M.
    Mccarthy, D.
    Kearney, C.
    Collins, A.
    Sundararajan, V.
    Rhee, J.
    Philip, J.
    Emery, J.
    SUPPORTIVE CARE IN CANCER, 2024, 32 (05)
  • [45] Changing trends in the global burden of polycystic ovarian syndrome-related infertility over the past 30 years: retrospective data analysis of the global burden of disease study 2019
    Ming Huo
    Yixiang Wang
    Xianbin Yuan
    Yue Yuan
    Xuehong Zhang
    BMC Women's Health, 25 (1)
  • [46] The Burden of Diabetes Mellitus in Patients with Coronary Heart Disease: A Methodological Approach to Assess Quality-Adjusted Life-Years Based on Individual-Level Longitudinal Survey Data
    Laxy, Michael
    Hunger, Matthias
    Stark, Renee
    Meisinger, Christa
    Kirchberger, Inge
    Heier, Margit
    von Scheidt, Wolfgang
    Holle, Rolf
    VALUE IN HEALTH, 2015, 18 (08) : 969 - 976
  • [47] ECONOMIC BURDEN OF DISEASE IN PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION USING COMMON DATA MODEL IN SOUTH KOREA
    Choi, K.
    Park, S. J.
    Han, S.
    Suh, H. S.
    VALUE IN HEALTH, 2022, 25 (07) : S344 - S345
  • [48] Economic Burden of Illness Among Commercially Insured Patients with Systemic Sclerosis with Interstitial Lung Disease in the USA: A Claims Data Analysis
    Zhou, Zhou
    Fan, Yanni
    Thomason, Darren
    Tang, Wenxi
    Liu, Xinyue
    Zhou, Zheng-Yi
    Macaulay, Dendy
    Fischer, Aryeh
    ADVANCES IN THERAPY, 2019, 36 (05) : 1100 - 1113
  • [49] Economic Burden of Illness Among Commercially Insured Patients with Systemic Sclerosis with Interstitial Lung Disease in the USA: A Claims Data Analysis
    Zhou Zhou
    Yanni Fan
    Darren Thomason
    Wenxi Tang
    Xinyue Liu
    Zheng-Yi Zhou
    Dendy Macaulay
    Aryeh Fischer
    Advances in Therapy, 2019, 36 : 1100 - 1113
  • [50] The health services burden of heart failure: an analysis using linked population health data-sets (vol 12, pg 103, 2012)
    Robertson, Jane
    McElduff, Patrick
    Pearson, Sallie-Anne
    Henry, David A.
    Inder, Kerry J.
    Attia, John R.
    BMC HEALTH SERVICES RESEARCH, 2013, 13